1Whelan T,Clark R,Robert R,et al. Ipsilateral breast tumor recurrence: postlumpectomy is predictive of sub-sequeut mortality:results from a randomized trial. Int J Radiat Oncol Phys Biol,1994,30:1.
3Hartsell WF,Recine DC,Griem KL,et al. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurreuce. Cancer, 1995,76:2497.
4van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term resuhs of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment Cancer 10801 trial. J Natl Cancer Ins,2000,92 : 1143-1150.
5Strom EA. Breast IMRT: new tools leading to new vision. Int J Radiat Oncol Biol Phys,2002,54 : 1297-1298.
6Colette L, Fourquet A, Horiot JC, et al. Impact of a boost dose of 16 Gy on local control in patients with early breast cancer: the EORTC boost versus no boost trial. Radiother Oncol, 2001,56 ( Suppl 1 ) : s46.
7Whelan T, Clark R, Robert R, et al. Ipsilateral breast tumor recurrence : postlumpectomy is predictive of sub-sequeut mortality: resuits from a randomized trial. Int J Radiat Oncol Phys Biol, 1994, 30:11.
8Van Asselen B, Raaijmakers CP, Hofman P, et al. An improved breast irradiation technique using three dimensional geometrical information and intensity modulation. Radiother Oncol, 2001,58 : 341-347.
9Landau D, A dams FJ, Webb S, et al. Cardiac idance in breast radio therapy: a comparison of simple shielding techniques with intensity modulated radiotherapy. Radiother Oncol, 2001,60:247.
10van Dongen JA,Voogd AC,Fentiman IS,et al. Long-tern results of a randomized trial comparing breast-COIlsewing therapy mastectomy:Eurepean Organization for Research and Treatment Caqfgt 10801trial[J] Natl Cancer Ins ,2000,92(3): 1143- 1150.
